Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment

Mastorino, L; Dapavo, P; Susca, S; Cariti, C; Siliquini, N; Verrone, A; Stroppiana, E; Ortoncelli, M; Quaglino, P; Ribero, S

Mastorino, L (通讯作者)，Univ Turin, Dept Med Sci, Sect Dermatol, Via Cherasco 23, I-10126 Turin, Italy.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023; ():

Abstract

Background: Biologics targeting IL-23 and IL-17 show efficacy and safety in the treatment of moderate-to-severe psoriasis.Objective: To investigate dr......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索